Email updates

Keep up to date with the latest news and content from AACI and BioMed Central.

Open Access Highly Accessed Review

CSACI Position statement on the testing of food-specific IgG

Stuart Carr1*, Edmond Chan2, Elana Lavine3 and William Moote4

Author Affiliations

1 University of Alberta, Department of Pediatrics, Division of Allergy and Immunology, 903 College Plaza 8215-112 Street, Edmonton, AB, T6G 2C8, Canada

2 BC Children’s Hospital, Department of Pediatrics, Division of Allergy, Room 1C31B – 4480 Oak Street, Vancouver, BC, V6H 3 V4, Canada

3 Humber River Regional Hospital, Department of Pediatrics, Pediatric Allergy Clinic, Suite 103 – 2115 Finch Ave West, Toronto, ON, M3N 2 V6, Canada

4 University of Western Ontario, Department of Medicine, Division of Clinical Immunology and Allergy, South Street Campus 2064 – 375 South Street, London, ON, N6A 4 G5, Canada

For all author emails, please log on.

Allergy, Asthma & Clinical Immunology 2012, 8:12  doi:10.1186/1710-1492-8-12

Published: 26 July 2012

First paragraph (this article has no abstract)

The Canadian Society of Allergy and Clinical Immunology (CSACI) is very concerned about the increased marketing of food-specific immunoglobulin G (IgG) testing towards the general public over the past few years, supposedly as a simple means by which to identify “food sensitivity”, food intolerance or food allergies. In the past, this unvalidated form of testing was usually offered by alternative or complementary health providers, but has now become more widely available with direct-to-consumer marketing through a nationwide chain of pharmacies.